Answers are grounded in this paper and cite their sources.
This assessment tool helps contextualize symptoms in severe asthma, suggesting better management strategies.
CPET may represent a valuable physiological adjunct in selected patients with difficult-to-treat or severe asthma and persistent exertional dyspnea insufficiently explained by resting assessments. Its integration into the assessment pathway may help contextualize symptoms, distinguish asthma-driven exercise limitation from non-inflammatory or non-asthmatic causes of dyspnea, and support more mechanism-based management. However, current evidence supports CPET primarily as a tool for physiological phenotyping and trait reclassification rather than as a prospectively validated guide to treatment escalation, biologic stewardship, or long-term outcome improvement.
No takes yet. Share an insight, caveat, or question.
Floriani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: